Abstract
The aim of the present thesis was to obtain insight into possible regulatory effects of androgens on the regulation of lipolysis in subcutaneous as well as visceral adipose tissue in women with the polycystic ovary syndrome (PCOS).
In non-obese women with PCOS, adrenergic lipolysis was investigated in both subcutaneous abdominal and visceral adipose tissue and several, novel disturbances were found. In subcutaneous adipose tissue, there was a markedly impaired lipolysis, due to ~10-fold decreased beta2-AR sensitivity as well as 50% reduced 02-AR density and a novel mechanism in the PKA-HSL complex, together reducing the activation of hormone sensitive lipase (HSL). Combined oral contraceptives (OC) therapy did not change the impaired lipolysis. The visceral adipose tissue lipolysis was enhanced by again stoichiometric changes in the PKA complex subunits.
These abnormalities promotes accumulation of fat in abdominal subcutaneous depot and "bum off' fat in the visceral depot, thus exposing the liver to a high FFA flux, which could contribute to dyslipidemia and hepatic insulin resistance. This is supported by anthropometric data on fat cell size and computed tomography (CT) of fat depots.
In obese subjects with PCOS, weight reduction was more effective than oral contraceptives in restoring at least in part, some defects in lipolysis in subcutaneous abdominal tissue. This indicates that in obese subjects, insulin resistance seems more important, than sex steroids in regulation of lipolysis. However in lean healthy women, ovarian downregulation, showed an impairment of catecholamine lipolysis, due to Mold decreased beta1-AR sensitivity, without affecting insulin sensitivity or the lipolysis responsiveness, speaking for a complex role of sex steroids in regulation of adipose tissue lipolysis.
Further investigations are needed to clarify the relationships between the different sex steroids in the regulation of lipolysis, both in PCOS and in healthy women.
